Published in
Wiley, Medicinal Research Reviews, 3(41), p. 1255-1290, 2021
DOI: 10.1002/med.21760
Links
Tools
Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 